Correlation Between Cardio Diagnostics and Phio Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Phio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Phio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cardio Diagnostics Holdings and Phio Pharmaceuticals Corp, you can compare the effects of market volatilities on Cardio Diagnostics and Phio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Phio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Phio Pharmaceuticals.

Diversification Opportunities for Cardio Diagnostics and Phio Pharmaceuticals

0.04

Correlation Coefficient

Cardio Diagnostics  Phio Pharmaceuticals

Significant diversification

The 3 months correlation between Cardio and Phio is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Phio Pharmaceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phio Pharmaceuticals Corp and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Phio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phio Pharmaceuticals Corp has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Phio Pharmaceuticals go up and down completely randomly.

Pair Corralation between Cardio Diagnostics and Phio Pharmaceuticals

Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to under-perform the Phio Pharmaceuticals. In addition to that, Cardio Diagnostics is 1.03 times more volatile than Phio Pharmaceuticals Corp. It trades about -0.2 of its total potential returns per unit of risk. Phio Pharmaceuticals Corp is currently generating about 0.04 per unit of volatility. If you would invest  181.00  in Phio Pharmaceuticals Corp on February 14, 2025 and sell it today you would earn a total of  1.00  from holding Phio Pharmaceuticals Corp or generate 0.55% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cardio Diagnostics Holdings  vs.  Phio Pharmaceuticals Corp

Cardio Diagnostics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cardio Diagnostics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in June 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Phio Pharmaceuticals Corp

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Phio Pharmaceuticals Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Phio Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cardio Diagnostics and Phio Pharmaceuticals

The main advantage of trading using opposite Cardio Diagnostics and Phio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Phio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phio Pharmaceuticals will offset losses from the drop in Phio Pharmaceuticals' long position.

The idea behind Cardio Diagnostics Holdings and Phio Pharmaceuticals Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.